PF Equity Holdings 2 B.V. 4
4 · Allogene Therapeutics, Inc. · Filed Apr 4, 2022
Insider Transaction Report
Form 4Exit
PF Equity Holdings 2 B.V.
10% Owner
Transactions
- Other
Common Stock
[F1]2022-03-31−22,032,040→ 0 total
Footnotes (1)
- [F1]Shares transferred to its parent entity, Pfizer Inc., for no cash consideration.
Signature
/s/Susan E. Grant, Attorney-in-fact on behalf of PF Equity Holdings 2 B.V.|2022-04-04